Book Volume 166 2005

Tumor Prevention and Genetics III


ISBN: 978-3-540-22228-6 (Print) 978-3-540-26980-9 (Online)

Table of contents (20 chapters)

  1. Front Matter

    Pages I-VI

  2. Chapter

    Pages 1-15

    Lifestyle and Medical Approaches to Cancer Prevention

  3. Chapter

    Pages 17-33

    Application of Genetics to the Prevention of Colorectal Cancer

  4. Chapter

    Pages 35-46

    Genetics and Prevention of Oesophageal Adenocarcinoma

  5. Chapter

    Pages 47-62

    Preclinical Models Relevant to Diet, Exercise, and Cancer Risk

  6. Chapter

    Pages 63-70

    Individualizing Interventions for Cancer Prevention

  7. Chapter

    Pages 71-88

    Can Animal Models Help Us Select Specific Compounds for Cancer Prevention Trials?

  8. Chapter

    Pages 89-98

    Problems with Using Biomarkers as Surrogate End Points for Cancer: A Cautionary Tale

  9. Chapter

    Pages 99-112

    Can a Marker Be a Surrogate for Development of Cancer, and Would We Know It if It Exists?

  10. Chapter

    Pages 113-124

    How Should We Move the Field of Chemopreventive Agent Development Forward in a Productive Manner?

  11. Chapter

    Pages 125-144

    The Problems with Risk Selection; Scientific and Psychosocial Aspects

  12. Chapter

    Pages 145-165

    Chemoprevention of Lung Cancer

  13. Chapter

    Pages 167-175

    Anti-nicotine Vaccination: Where Are We?

  14. Chapter

    Pages 177-211

    Primary Prevention of Colorectal Cancer: Lifestyle, Nutrition, Exercise

  15. Chapter

    Pages 213-230

    Chemoprevention of Colorectal Cancer: Ready for Routine Use?

  16. Chapter

    Pages 231-244

    Screening of Colorectal Cancer: Progress and Problems

  17. Chapter

    Pages 245-256

    The Role of Endogenous Hormones in the Etiology and Prevention of Breast Cancer: The Epidemiological Evidence

  18. Chapter

    Pages 257-275

    Innovative Agents in Cancer Prevention

  19. Chapter

    Pages 277-297

    The IARC Commitment to Cancer Prevention: The Example of Papillomavirus and Cervical Cancer

  20. Chapter

    Pages 299-313

    Health Economics in the Genomic Age

  21. Chapter

    Pages 315-334

    Screening for Cancer: Are Resources Being Used Wisely?